Green Genome India: Democratizing Genomics For A Healthier & Inclusive India

Simardeep Singh Chhabra, Founder

Simardeep Singh Chhabra

Founder

In a country as vast and demographically complex as In­dia, healthcare continues to be one of the most urgent and layered challenges. Despite impressive strides in biotechnology, diagnostics, and artificial intelligence, the benefits of these advances seldom reach the rural and un­derserved populations that form the backbone of the nation.

Infrastructure bottlenecks, linguistic diversity, limited ge­nomic literacy, and a widening burden of non-communica­ble diseases (NCDs) only deepen the gap between innova­tion and access. To bridge this divide, India needs scalable, culturally rooted, and inclusive health technologies that ad­dress real-world conditions.

A biotechnology and bioinformatics firm, Green Genome India, is responding to this call with an ambitious and revolutionary vision. With a mission to democratize precision health and make genomic science accessible across Tier II and Tier III cities, the firm is reshaping how healthcare is delivered by bringing it out of elite labs into primary care settings, mobile health units, school screenings, and rural households.

Founded on the philosophy that healthcare should be predictive, individualized, and fair, the firm is endeavoring to indigenize sophisticated diagnostics and given human faces to health data via new, community-based modes of delivery.

A Holistic Healthtech Model

The firm has an end-to-end product offering, including early-stage research and development, clinical validation, and large-scale implementation. Its flagship innovations include saliva-based diagnostic kits tailored for rural and tribal populations, offering a non-invasive, culturally sensitive alternative to blood-based screening.

Affirming its technology is a deep commitment to education by training frontline workers such as ASHAs, ANMs, and rural lab technicians in local languages, so that they can interpret genomic data and become drivers of local health change.

What sets Green Genome apart is its systems-thinking approach and ability to operate across sectors. Crop trait mapping, soil microbiome, and veterinary pathogen surveillance initiatives are just a few examples that illustrate its dedication to the One Health approach, where a biological continuum exists between ecosystems, animals, and humans. “The inclusion of environmental information in NCD risk models shows the advanced vision of Green Genome ecosystem-based precision health, expanding the limits of what is considered conventional biotech to solve highly interconnected issues”, says Simardeep Singh Chhabra, Founder, Green Genome India.

The inclusion of environmental information in NCD risk models shows the advanced vision of Green Genome ecosystem-based precision health, expanding the limits of what is considered conventional biotech to solve highly interconnected issues

Simardeep Singh Chhabra, Founder

Empowering Scientists, Enabling Systems

In addition to technology, Green Genome cares strongly about ethical innovation. “We have developed community consent frameworks to safeguard the rights of tribal and rural populations whose genetic data is often harvested without transparency or benefit sharing,” mentions Chhabra. The firm focuses on keeping knowledge production local and democratically controlled by developing open-access genomic interpretation tools to serve government hospitals and training Indian scientists as part of joint capacity-building initiatives. It adheres to the national standards of ICMR, NABL, and CDSCO, which demonstrates its commitment to scientific integrity.

The firm is also very instrumental in the initiatives of the public sector. It is seriously engaged in collaboration with the Indian Council of Medical Research (ICMR), the Department of Biotechnology, and different state governments to take care of the national health missions and other public health interventions.

As the COVID-19 pandemic occurred, the firm played a part in genomic surveillance and assisted health departments in diagnostic rollouts and interpretation of data in the field. These collaborations are characteristic of how the firm can develop its science to benefit large populations and remain in the realm of the common good.

Building Genomic Literacy in Rural India

Central to the Green Genome model is its transformative “HealthTech-to-Hands” training program that seeks to develop a genomically literate rural workforce. By treating ANMs, GNMs, and primary care providers not as secondary users but as primary actors, the firm has reimagined rural skill-building. The program consists of courses in genomics, non-invasive sample processing, AI-based diagnostics, and introductory genetic counseling, all of which are supported by multilingual, low-bandwidth, mobile-first channels.

A “Train-the-Trainer” model ensures scalability, while planned simulation labs in district centers offer hands-on learning through real-world scenarios. The workforce empowerment model is developed to not only inform but to create professional pride, trust of the community, and sustained behavioral change.

The key to this effect-oriented paradigm is the unusual mixture of scientific rigor and human understanding demonstrated by Chhabra. He has a strong background in rural health systems as well as in next-generation genomic technologies and is known for his visits to the field and work at the grassroots level.

His advocacy of iterative design, social responsibility, and participatory innovation has contributed to the development of an organizational culture that listens before it leads. Green Genome, led by him, is not a mere startup but a movement towards bringing science to serve everyone, everywhere.

Charting the Next Frontier in Precision Health & Data Equity

Looking ahead, Green Genome India is poised to become a cornerstone of India’s precision health revolution. The firm is currently developing India’s first large-scale, saliva- and urine-based biomarker platform for early detection of cancer and NCDs. It is also building an open-access genomic registry aligned with the Ayushman Bharat Digital Health Mission, aiming to create a shared, secure, and inclusive health data infrastructure.

Future to add, the road ahead for the firm includes expanding the One Health framework in partnership with ICMR and ICAR, launching five regional training hubs, and equipping over 50,000 rural health workers across 10 states by 2027 through collaborations with nursing councils and medical colleges.

“With these ambitious steps, Green Genome India is laying the foundation for a health-sovereign, genomically empowered, and socially equitable future for all Indians”, concludes Chhabra.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.